TEMPUS RIC, LLC — SEC Form D Filing

TEMPUS RIC, LLC filed an SEC Form D on April 9, 2026, reporting $1.34M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
April 9, 2026
Amount reported
$1.34M
Round stage
Series A
Industry
Healthcare Technology
Website
https://www.tempus.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: ARKANSAS

Problem

Tempus addresses the challenges of precision medicine by helping healthcare providers, pharmaceutical companies, and patients navigate complex treatment options and identify personalized therapies.

Solution

Tempus leverages AI and extensive data to accelerate the discovery of treatments, connect patients to clinical trials, and provide actionable insights to healthcare providers.

Verdict

Investors backed Tempus RIC at this moment due to a growing demand for precision medicine, betting on the company’s ability to harness AI for therapeutic discovery and clinical trial navigation. This cleared because it presented a fresh approach to a pressing healthcare challenge, not because it was the first to target the space. The limited upside stems from potential competition and the crowded landscape of healthcare tech, where differentiation can be fleeting.

Source: SEC EDGAR Form D filing